Virpax Pharmaceuticals Stock Forecast - Simple Moving Average
| VRPX Stock | USD 3.47 0.06 1.70% |
The Simple Moving Average forecasted value of Virpax Pharmaceuticals on the next trading day is expected to be 3.47 with a mean absolute deviation of 0.23 and the sum of the absolute errors of 13.44. Virpax Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Virpax Pharmaceuticals stock prices and determine the direction of Virpax Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Virpax Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Virpax Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Virpax Pharmaceuticals' systematic risk associated with finding meaningful patterns of Virpax Pharmaceuticals fundamentals over time.
Check out Historical Fundamental Analysis of Virpax Pharmaceuticals to cross-verify your projections. Virpax |
Most investors in Virpax Pharmaceuticals cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Virpax Pharmaceuticals' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Virpax Pharmaceuticals' price structures and extracts relationships that further increase the generated results' accuracy.
A two period moving average forecast for Virpax Pharmaceuticals is based on an daily price series in which the stock price on a given day is replaced by the mean of that price and the preceding price. This model is best suited to price patterns experiencing average volatility. Virpax Pharmaceuticals Simple Moving Average Price Forecast For the 19th of April
Given 90 days horizon, the Simple Moving Average forecasted value of Virpax Pharmaceuticals on the next trading day is expected to be 3.47 with a mean absolute deviation of 0.23, mean absolute percentage error of 0.1, and the sum of the absolute errors of 13.44.Please note that although there have been many attempts to predict Virpax Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Virpax Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Virpax Pharmaceuticals Stock Forecast Pattern
| Backtest Virpax Pharmaceuticals | Virpax Pharmaceuticals Price Prediction | Buy or Sell Advice |
Virpax Pharmaceuticals Forecasted Value
In the context of forecasting Virpax Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Virpax Pharmaceuticals' downside and upside margins for the forecasting period are 0.03 and 10.93, respectively. We have considered Virpax Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Virpax Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Virpax Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 112.1143 |
| Bias | Arithmetic mean of the errors | -0.0102 |
| MAD | Mean absolute deviation | 0.2278 |
| MAPE | Mean absolute percentage error | 0.0614 |
| SAE | Sum of the absolute errors | 13.44 |
Predictive Modules for Virpax Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Virpax Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Virpax Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Virpax Pharmaceuticals
For every potential investor in Virpax, whether a beginner or expert, Virpax Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Virpax Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Virpax. Basic forecasting techniques help filter out the noise by identifying Virpax Pharmaceuticals' price trends.Virpax Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Virpax Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Virpax Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Virpax Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Virpax Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Virpax Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Virpax Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Virpax Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Virpax Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Virpax Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Virpax Pharmaceuticals stock market strength indicators, traders can identify Virpax Pharmaceuticals entry and exit signals to maximize returns.
Virpax Pharmaceuticals Risk Indicators
The analysis of Virpax Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Virpax Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting virpax stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.62 | |||
| Semi Deviation | 6.64 | |||
| Standard Deviation | 7.3 | |||
| Variance | 53.27 | |||
| Downside Variance | 48.86 | |||
| Semi Variance | 44.12 | |||
| Expected Short fall | (6.84) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Virpax Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Virpax Pharmaceuticals' short interest history, or implied volatility extrapolated from Virpax Pharmaceuticals options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Virpax Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Virpax Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Virpax Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Virpax Pharmaceuticals Stock:Check out Historical Fundamental Analysis of Virpax Pharmaceuticals to cross-verify your projections. For more information on how to buy Virpax Stock please use our How to Invest in Virpax Pharmaceuticals guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Virpax Stock analysis
When running Virpax Pharmaceuticals' price analysis, check to measure Virpax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virpax Pharmaceuticals is operating at the current time. Most of Virpax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Virpax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virpax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Virpax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
Is Virpax Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Virpax Pharmaceuticals. If investors know Virpax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Virpax Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (12.97) | Return On Assets (0.55) | Return On Equity (1.64) |
The market value of Virpax Pharmaceuticals is measured differently than its book value, which is the value of Virpax that is recorded on the company's balance sheet. Investors also form their own opinion of Virpax Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Virpax Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virpax Pharmaceuticals' market value can be influenced by many factors that don't directly affect Virpax Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virpax Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Virpax Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virpax Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.